QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: jpet.103.051920v1 307/1/129    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wallace, M. J. Articles by DeLorenzo, R. J. Search for Related Content PubMed PubMed Citation Articles by Wallace, M. J. Articles by DeLorenzo, R. J.

NEUROPHARMACOLOGY

The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy

Departments of Neurology (R.E.B., R.J.D.), Pharmacology and Toxicology (M.J.W., K.W.F., B.R.M., R.J.D.), and Molecular Biophysics and Biochemistry (R.J.D.), Virginia Commonwealth University, Richmond, Virginia

Several lines of evidence suggest that cannabinoid compounds are anticonvulsant. However, the anticonvulsant potential of cannabinoids and, moreover, the role of the endogenous cannabinoid system in regulating seizure activity has not been tested in an in vivo model of epilepsy that is characterized by spontaneous, recurrent seizures. Here, using the rat pilocarpine model of epilepsy, we show that the marijuana extract ⁹-tetrahydrocannabinol (10 mg/kg) as well as the cannabimimetic, 4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one [R(+)WIN55,212 (5 mg/kg)], completely abolished spontaneous epileptic seizures. Conversely, application of the cannabinoid CB₁ receptor (CB₁) antagonist, N-(piperidin-1-yl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamidehydrochloride (SR141716A), significantly increased both seizure duration and frequency. In some animals, CB₁ receptor antagonism resulted in seizure durations that were protracted to a level consistent with the clinical condition status epilepticus. Furthermore, we determined that during an short-term pilocarpine-induced seizure, levels of the endogenous CB₁ ligand 2-arachidonylglycerol increased significantly within the hippocampal brain region. These data indicate not only anticonvulsant activity of exogenously applied cannabinoids but also suggest that endogenous cannabinoid tone modulates seizure termination and duration through activation of the CB₁ receptor. Furthermore, Western blot and immunohistochemical analyses revealed that CB₁ receptor protein expression was significantly increased throughout the CA regions of epileptic hippocampi. By demonstrating a role for the endogenous cannabinoid system in regulating seizure activity, these studies define a role for the endogenous cannabinoid system in modulating neuroexcitation and suggest that plasticity of the CB₁ receptor occurs with epilepsy.

Address correspondence to: Dr. Robert J. DeLorenzo, Virginia Commonwealth University, School of Medicine, P.O. Box 980599, Richmond, VA. E-mail: rdeloren{at}hsc.vcu.edu

This article has been cited by other articles:

				A. Ludanyi, L. Eross, S. Czirjak, J. Vajda, P. Halasz, M. Watanabe, M. Palkovits, Z. Magloczky, T. F. Freund, and I. Katona Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus J. Neurosci., March 19, 2008; 28(12): 2976 - 2990. [Abstract] [Full Text] [PDF]

				D. A. Karanian, S. L. Karim, J. T. Wood, J. S. Williams, S. Lin, A. Makriyannis, and B. A. Bahr Endocannabinoid Enhancement Protects against Kainic Acid-Induced Seizures and Associated Brain Damage J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1059 - 1066. [Abstract] [Full Text] [PDF]

				A. L. Howard, A. Neu, R. J. Morgan, J. C. Echegoyen, and I. Soltesz Opposing Modifications in Intrinsic Currents and Synaptic Inputs in Post-Traumatic Mossy Cells: Evidence for Single-Cell Homeostasis in a Hyperexcitable Network J Neurophysiol, March 1, 2007; 97(3): 2394 - 2409. [Abstract] [Full Text] [PDF]

				K. Chen, A. Neu, A. L. Howard, C. Foldy, J. Echegoyen, L. Hilgenberg, M. Smith, K. Mackie, and I. Soltesz Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures J. Neurosci., January 3, 2007; 27(1): 46 - 58. [Abstract] [Full Text] [PDF]

				D. A. Fortin and E. S. Levine Differential Effects of Endocannabinoids on Glutamatergic and GABAergic Inputs to Layer 5 Pyramidal Neurons Cereb Cortex, January 1, 2007; 17(1): 163 - 174. [Abstract] [Full Text] [PDF]

				A. Neu, C. Foldy, and I. Soltesz Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus J. Physiol., January 1, 2007; 578(1): 233 - 247. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				R. E. Blair, L. S. Deshpande, S. Sombati, K. W. Falenski, B. R. Martin, and R. J. DeLorenzo Activation of the Cannabinoid Type-1 Receptor Mediates the Anticonvulsant Properties of Cannabinoids in the Hippocampal Neuronal Culture Models of Acquired Epilepsy and Status Epilepticus J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1072 - 1078. [Abstract] [Full Text] [PDF]

				A. Witting, L. Chen, E. Cudaback, A. Straiker, L. Walter, B. Rickman, T. Moller, C. Brosnan, and N. Stella From the Cover: Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection PNAS, April 18, 2006; 103(16): 6362 - 6367. [Abstract] [Full Text] [PDF]

				E. Shohami and R. Mechoulam Multiple sclerosis may disrupt endocannabinoid brain protection mechanism PNAS, April 18, 2006; 103(16): 6087 - 6088. [Full Text] [PDF]

				P. L. Pearl, E. L. Robbins, H. D. Bennett, and J. A. Conry Use of Complementary and Alternative Therapies in Epilepsy: Cause for Concern Arch Neurol, September 1, 2005; 62(9): 1472 - 1475. [Full Text] [PDF]

				C. Bernard, M. Milh, Y. M. Morozov, Y. Ben-Ari, T. F. Freund, and H. Gozlan Altering cannabinoid signaling during development disrupts neuronal activity PNAS, June 28, 2005; 102(26): 9388 - 9393. [Abstract] [Full Text] [PDF]

				M. Raza, R. E. Blair, S. Sombati, D. S. Carter, L. S. Deshpande, and R. J. DeLorenzo Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy PNAS, December 14, 2004; 101(50): 17522 - 17527. [Abstract] [Full Text] [PDF]